Certified by Founder Lodge
BioLamina
Sweden - Sundbyberg
START UP
1 Disclosed Funding Rounds $18,216,000
0 Participating Investments
-
Founded date
2009
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BioLamina is a Swedish biotechnology company with a global presence, offering cell culture matrices for primary cells. We offer an expansive portfolio of recombinant laminin proteins for a va
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 12 ,2023 | Unknown | $18,216,000 |
LAUXERA CAPITAL PARTNERS
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Naoma AI | $440,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
